Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
alexion pharmaceuticals
alnylam pharmaceuticals
antisense oligonucleotide
benzodiazepines
biogen
blackstone group
blackstone life sciences
boehringer ingelheim
columbia university
david goldstein
deals
depression
dicerna pharamceuticals
epi4k
epilepsy
essential tremor
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
investing
kiran reddy
major depressive disorder
marcio souza
new york blog main
new york top stories
patisiran
perimenopausal depression
praxis precision medicines
ptc therapeutics
rna interference
roche
What
medicines
research
stop
2
×
aims
backed
caught
cause
causing
ceo
dicerna
disease
drug
drugs
epilepsy
eye
gene
genes
genetic
hepatitis
intended
links
marcio
mutations
neuro
new
pay
pharma
pharmaceuticals
praxis
precision
producing
protein
roche
souza
team
turn
Language
unset
Current search:
stop
×
boston
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
